EXACT Therapeutics AS is a clinical stage biopharmaceutical company, which engages in the research and development of novel platform for ultrasound mediated therapeutic amplification. It focuses on Acoustic Cluster Therapy (ACT) platform, an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology, infectious diseases, and neurological conditions. The company was founded by Svein Kvale, Per Christian Sontum, and Andrew John Healey in 2012 and is headquartered in Oslo, Norway.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company